Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BCYC will decline by -13.92% over the next 2 Weeks and hit $4.93 by Wednesday, March 11, 2026. In that time frame, BCYC's share price is expected to range between $4.59 and $5.28.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 11, 2026 | 4.59 | 4.93 | 5.28 |
| Mar 10, 2026 | 4.61 | 4.94 | 5.26 |
| Mar 9, 2026 | 4.92 | 5.24 | 5.55 |
| Mar 6, 2026 | 4.81 | 5.14 | 5.46 |
| Mar 5, 2026 | 4.87 | 5.19 | 5.53 |
| Mar 4, 2026 | 4.96 | 5.30 | 5.63 |
| Mar 3, 2026 | 4.97 | 5.31 | 5.65 |
| Mar 2, 2026 | 5.29 | 5.60 | 5.94 |
| Feb 27, 2026 | 5.18 | 5.50 | 5.84 |
| Feb 26, 2026 | 5.24 | 5.56 | 5.87 |
BCYC shares rose +1.96% in Wednesday, February 25, 2026's trading session, rising from a previous close of $5.62 to move at $5.73. The stock demonstrated notable intraday movement (see BCYC's key stats for a full breakdown), fluctuating between $5.55 and $5.89, a +6.13% trading range. While recent weeks have seen some volatility, BCYC has managed to secure a +3.43% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.43M shares changing hands, 1.02M more than the previous session. This amounted to $8.20M in total market activity.
Will BCYC Continue Its Downward Trend?
According to analyst ratings and projections for BCYC, Bicycle Therapeutics plc shares are anticipated to decrease by -8.47%, potentially reaching $5.28 per share by March 11, 2026. Short-term technical indicators currently suggest a neutral sentiment for BCYC. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the BCYC stock forecast, now is not the best time to buy BCYC stock because its current trading price is +16.17% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BCYC covering social and institutional perspectives.
BCYC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BCYC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.37% to 51.35%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.68%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.90%, maintains a neutral outlook for the long term. Insights into BCYC's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Bicycle Therapeutics Short-Term Forecasts
BCYC Forecast For Next 5 Days
Our algorithm anticipates Bicycle Therapeutics (BCYC) stock could hit $5.29 by Mar 04, 2026. This represents a -7.70% rise from today's price, following a +1.37% change over the past five days.
BCYC Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Bicycle Therapeutics plc (BCYC) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $4.68, which would mean a -18.32% decrease from the current price of $5.73. Projections for this period range from a high of $6.19 to a low of $3.54.
BCYC Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Bicycle Therapeutics's price over the next three months point to a rise. BCYC stock is expected to peak at $9.84 on Mar 23, 2026 before potentially dipping to $6.54 on Apr 27, 2026. On average, BCYC is likely to trade around $8.41 in the coming 90 days.
Bicycle Therapeutics Stock Forecast 2025
Based on our predictive models, Bicycle Therapeutics (BCYC) is expected to trade between $0.00 and $9.84 throughout 2026. This would result in an average price of $7.52, potentially offering investors a +31.24% return from current levels.
Bicycle Therapeutics plc Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Bicycle Therapeutics plc (BCYC) is positioned to show a strong performance in February 2026. The price is predicted to move between $8.68 and $9.46, settling at an average of $9.06. This could translate to a +58.12% gain.
March 2026
Based on current market signals, Bicycle Therapeutics plc is projected to trend march 2026. We forecast a trading range from $8.46 to $9.84, with a likely average price of $9.16. Investors could expect a potential return of +59.86%.
April 2026
Our predictive algorithms indicate Bicycle Therapeutics plc stock may see a shift in April 2026. The expected range spans $6.54–$9.31, with an average target of $7.74. This represents a positive outlook and a possible gain of +35.08%.
May 2026
Analyzing established trends, Bicycle Therapeutics plc looks set to move in May 2026. Projections place the stock between $6.83 and $8.65, averaging around $8.21. This suggests a +43.28% gain from current levels.
June 2026
Market indicators suggest Bicycle Therapeutics plc could experience notable changes during June 2026. Prices could fluctuate within $4.65 to $8.48, with a midpoint forecast of $7.62. The stock might deliver a +32.98% gain.
July 2026
Forecasting for July 2026, models estimate that Bicycle Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $3.83 and $6.79, averaging $6.95. This signals a positive trajectory with potential returns around +21.29%.
August 2026
According to our latest forecast models, Bicycle Therapeutics plc (BCYC) is positioned to show a strong performance in August 2026. The price is predicted to move between $1.94 and $6.65, settling at an average of $7.33. This could translate to a +27.92% gain.
September 2026
Based on current market signals, Bicycle Therapeutics plc is projected to trend september 2026. We forecast a trading range from $0.00 to $6.16, with a likely average price of $7.17. Investors could expect a potential return of +25.13%.
October 2026
Our predictive algorithms indicate Bicycle Therapeutics plc stock may see a shift in October 2026. The expected range spans $0.00–$6.08, with an average target of $7.94. This represents a positive outlook and a possible gain of +38.57%.
November 2026
Analyzing established trends, Bicycle Therapeutics plc looks set to move in November 2026. Projections place the stock between $0.00 and $5.06, averaging around $6.77. This suggests a +18.15% gain from current levels.
December 2026
Market indicators suggest Bicycle Therapeutics plc could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $3.37, with a midpoint forecast of $6.23. The stock might deliver a +8.73% gain.
January 2027
Forecasting for January 2027, models estimate that Bicycle Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.08, averaging $6.12. This signals a positive trajectory with potential returns around +6.81%.
February 2027
According to our latest forecast models, Bicycle Therapeutics plc (BCYC) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $3.45, settling at an average of $5.37. This could translate to a -6.28% loss.
BCYC's history of dividends and stock splits also plays a role in long-term investor confidence.